| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-09 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |